BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$24.00+25.9% vs. price
  • Buy 100%
Low $19.00Now $19.07Avg $24.00High $31.00

Recent rating changes

The last 20 actions on file set price targets from $9.00 to $31.00, averaging $18.95.

DateFirmRatingTarget
29 Oct 2026 Wedbush BUY $19.00
29 Oct 2026 Leerink Partners BUY $31.00
28 Oct 2026 Jefferies BUY $29.00
28 Oct 2026 BMO Capital BUY $20.00
10 Sep 2026 BMO Capital BUY $20.00
26 Aug 2026 J.P. Morgan BUY $21.00
17 Aug 2026 Wedbush BUY $19.00
17 Aug 2026 Jefferies BUY $24.00
17 Aug 2026 BMO Capital BUY $20.00
10 Aug 2026 J.P. Morgan BUY $20.00
7 Aug 2026 Piper Sandler BUY $14.00
7 Aug 2026 Wedbush BUY $19.00
7 Aug 2026 BMO Capital BUY $20.00
3 Aug 2026 Leerink Partners BUY $17.00
31 Jul 2026 Cantor Fitzgerald BUY –
31 Jul 2026 Piper Sandler BUY $14.00
31 Jul 2026 Wedbush HOLD $12.00
31 Jul 2026 BMO Capital BUY $16.00
28 Jul 2026 Wedbush HOLD $9.00
28 Jul 2026 BMO Capital BUY $16.00

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top